Abstract:Summary Background B cells can be enriched within meningeal immune-cell aggregates of multiple sclerosis (MS) patients, adjacent to subpial cortical demyelinating lesions now recognized as important contributors to progressive disease. This subpial demyelination is notable for a 'surface-in' gradient of neuronal loss and microglial activation, potentially reflecting the effects of soluble factors secreted into the CSF. We previously demonstrated that MS B-cell secreted products are toxic to oligodendrocytes and neurons. The potential for B-cell–myeloid cell interactions to propagate progressive MS is of considerable interest. Methods Secreted products of MS-implicated pro-inflammatory effector B cells or IL-10-expressing B cells with regulatory potential were applied to human brain-derived microglia or monocyte-derived macrophages, with subsequent assessment of myeloid phenotype and function through measurement of their expression of pro-inflammatory, anti-inflammatory and homeostatic/quiescent molecules, and phagocytosis (using flow cytometry, ELISA and fluorescently-labeled myelin). Effects of secreted products of differentially activated microglia on B-cell survival and activation were further studied. Findings Secreted products of MS-implicated pro-inflammatory B cells (but not IL-10 expressing B cells) substantially induce pro-inflammatory cytokine (IL-12, IL-6, TNFα) expression by both human microglia and macrophage (in a GM-CSF dependent manner), while down-regulating their expression of IL-10 and of quiescence-associated molecules, and suppressing their myelin phagocytosis. In contrast, secreted products of IL-10 expressing B cells upregulate both human microglia and macrophage expression of quiescence-associated molecules and enhance their myelin phagocytosis. Secreted factors from pro-inflammatory microglia enhance B-cell activation. Interpretation Potential cross-talk between disease-relevant human B-cell subsets and both resident CNS microglia and infiltrating macrophages may propagate CNS-compartmentalized inflammation and injury associated with MS disease progression. These interaction represents an attractive therapeutic target for agents such as Bruton's tyrosine kinase inhibitors (BTKi) that modulate responses of both B cells and myeloid cells. Funding Stated in Acknowledgments section of manuscript.

Proinflammatory mucosal-associated invariant CD8+ T cells react to gut flora yeasts and infiltrate multiple sclerosis brain

Gut Microbiota–specific IgA + B Cells Traffic to the CNS in Active Multiple Sclerosis

Intestinal microbiota composition and peripheral blood Th cell subsets in patients with multiple sclerosis

MAIT Cells and Microbiota in Multiple Sclerosis and Other Autoimmune Diseases

Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice

Gut microorganisms act together to exacerbate inflammation in spinal cords

Lymphatic system and gut microbiota affect immunopathology of neuroinflammatory diseases, including multiple sclerosis, neuromyelitis optica and Alzheimer's disease

Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis

Gut-Microbiota, and Multiple Sclerosis: Background, Evidence, and Perspectives

Bacteria–Fungi Interactions in Multiple Sclerosis

Circulating MAIT cells in multiple sclerosis and amyotrophic lateral sclerosis

Multiple sclerosis and mixed microbial infections. Direct identification of fungi and bacteria in nervous tissue

Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters

Multiple sclerosis and the intestine: Chasing the microbial offender

Cross-talk between B cells, microglia and macrophages, and implications to central nervous system compartmentalized inflammation and progressive multiple sclerosis

Interaction of the Gut Microbiome and Immunity in Multiple Sclerosis: Impact of Diet and Immune Therapy

Twin study identifies early immunological and metabolic dysregulation of CD8 + T cells in multiple sclerosis

The Gut Microbiota and Associated Metabolites in Multiple Sclerosis

Gastrointestinal Tract, Microbiota and Multiple Sclerosis (MS) and the Link Between Gut Microbiota and CNS

CD4 Trm sustain the chronic phase of auto-immune neuroinflammatory disease

Targeting the gut to treat multiple sclerosis